Idaho Secures $17.85M Settlement in Generic Drug Price-Fixing Cases

Attorney General Raúl R. Labrador announces Idaho's participation in multistate settlements with Lannett and Bausch Health over alleged price-fixing conspiracies.

Published on Feb. 12, 2026

Got story updates? Submit your updates here. ›

Idaho has joined 48 other states and territories in securing $17.85 million in settlements with pharmaceutical companies Lannett Company, Inc. and Bausch Health US, LLC and Bausch Health Americas, Inc. The settlements resolve allegations that the companies participated in long-running conspiracies to inflate prices and limit competition for numerous generic prescription drugs.

Why it matters

These settlements are part of a broader multistate litigation against 30 corporate defendants and 25 executives accused of generic drug price-fixing, which has already resulted in earlier agreements totaling $49.1 million. The price-fixing schemes forced Idaho families to pay artificially inflated costs for necessary medications.

The details

As part of the agreements, Lannett and Bausch will cooperate in the ongoing multistate litigation and implement internal compliance reforms. Idaho residents who purchased certain generic prescription drugs between May 1, 2009, and Dec. 31, 2019, may be eligible for compensation, and businesses that indirectly purchased or reimbursed eligible drugs during that period may also qualify.

  • The settlements were announced on February 12, 2026.
  • The broader case is headed to trial in Connecticut, expected in late 2026.

The players

Raúl R. Labrador

The Attorney General of Idaho who announced the state's participation in the settlements.

Lannett Company, Inc.

One of the pharmaceutical companies that reached a settlement with Idaho and other states over alleged generic drug price-fixing.

Bausch Health US, LLC and Bausch Health Americas, Inc.

The other pharmaceutical companies that reached a settlement with Idaho and other states over alleged generic drug price-fixing.

Got photos? Submit your photos here. ›

What they’re saying

“These drug companies conspired to rig prices and eliminate competition, forcing Idaho families to pay artificially inflated costs for necessary medications.”

— Raúl R. Labrador, Attorney General of Idaho (Press Release)

What’s next

The broader case is headed to trial in Connecticut, expected in late 2026.

The takeaway

This settlement is part of a larger multistate effort to hold pharmaceutical companies accountable for alleged generic drug price-fixing schemes that have burdened consumers and businesses with inflated medication costs. The cooperation and compliance reforms required of the settling companies may help prevent future price-fixing abuses.